Emboline Secures $20 Million Investment to Advance Stroke-Reducing Technology

Emboline, a medical technology company, obtains $20 million from Trinity Capital to support stroke-reducing initiatives and technology advancement.

AI-assisted, human-published

Latest headlines

Join us for funding and investment opportunities.

Stay connected!

If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here